93 7290 (Raloxifene Hydrochloride 60 mg)
Pill with imprint 93 7290 is White, Capsule-shape and has been identified as Raloxifene Hydrochloride 60 mg. It is supplied by Teva Pharmaceuticals.
Raloxifene is used in the treatment of breast cancer, prevention; osteoporosis; prevention of osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Raloxifene 60 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7290
Raloxifene Hydrochloride
- Imprint
- 93 7290
- Strength
- 60 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Hormones/antineoplastics, Selective estrogen receptor modulators
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (15 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 4000,
povidone k30,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7290 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0726 (Discontinued) | AvKare, Inc. |
More about raloxifene
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (17)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: hormones/antineoplastics
Patient resources
- Other brands
- Evista
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.